← Back to Search

Science-Based Treatment for Opioid Dependence

Phase 2

Waitlist Available

Led By Lisa Marsch, PhD

Research Sponsored by National Development and Research Institutes, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Ages 13-18 years

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

Study Summary

This trial is testing different ways to help opioid-dependent youth, using a combination of behavioral and drug treatments.

Who is the study for?

This trial is for teens aged 13-18 who are struggling with opioid addiction. They must be diagnosed with opioid dependence but can't join if they have severe mental health issues like psychosis or suicidal thoughts, serious physical health problems, are pregnant, or need inpatient detox for other drugs.Check my eligibility

What is being tested?

The study is looking at how to improve treatment results for young people addicted to opioids by combining medication and behavioral therapy. The exact nature of the treatments isn't specified here.See study design

What are the potential side effects?

While specific side effects aren't listed here, typical ones from treatments for opioid dependence may include nausea, headaches, dizziness, mood changes, and sleep disturbances.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 13 and 18 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

opiate use

Secondary outcome measures

HIV risk behavior

criminal activity

family relations

+6 more

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

St. Luke's-Roosevelt Hospital CenterOTHER

95 Previous Clinical Trials

18,256 Total Patients Enrolled

National Development and Research Institutes, Inc.Lead Sponsor

37 Previous Clinical Trials

12,866 Total Patients Enrolled

Lisa Marsch, PhDPrincipal InvestigatorNational Development and Research Institutes, Inc.

2 Previous Clinical Trials

146 Total Patients Enrolled

Media Library

Combined Behavioral-Pharmacological Treatment Clinical Trial Eligibility Overview. Trial Name: NCT00182572 — Phase 2

Opioid Dependence Research Study Groups:

Opioid Dependence Clinical Trial 2023: Combined Behavioral-Pharmacological Treatment Highlights & Side Effects. Trial Name: NCT00182572 — Phase 2

Combined Behavioral-Pharmacological Treatment 2023 Treatment Timeline for Medical Study. Trial Name: NCT00182572 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can I participate in this research endeavor?

"80 adolescents aged between 13 and 18 who suffer from opioid abuse are eligible to join this trial. The candidate must meet the age prerequisite of being within this specified range."

Answered by AI

Are applicants of any age admissible for this investigation?

"This research initiative is targeting participants aged between 13 and 18 years."

Answered by AI

What risk factors should be taken into consideration when using this therapy?

"The safety of this intervention was rated a 2 as it is currently undergoing Phase 2 trials, which means there are some data points attesting to its security but no evidence yet regarding efficacy."

Answered by AI

Are there currently any openings to join this research endeavor?

"The clinicaltrials.gov website reveals that recruitment for this trial has already concluded, with the initial posting on July 1st 2005 and last update from August 11th 2008. Fortunately, there are still 291 other trials actively seeking participants at present."

Answered by AI

Recent research and studies

AddictionJournal

A Randomized Controlled Trial of Buprenorphine Taper Duration Among Opioid-dependent Adolescents and Young Adults

Marsch, Lisa A., Sarah K. Moore, Jacob T. Borodovsky, Ramon Solhkhah, Gary J. Badger, Shelby Semino, Kate Jarrett, et al.. 2016. “A Randomized Controlled Trial of Buprenorphine Taper Duration Among Opioid-dependent Adolescents and Young Adults”. Addiction. Wiley. doi:10.1111/add.13363.

clinicaltrials.govStudy

Science-Based Treatment for Opioid-Dependent Adolescents

2005. "Science-Based Treatment for Opioid-Dependent Adolescents". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00182572.

All > Opioid Dependence > Addiction